Immunic (IMUX) Shareholder's Equity (2013 - 2026)
Immunic (IMUX) Shareholder's Equity (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
502.95 Mn |
| 10 |
Immunic |
384.84 Mn |
198.21 Mn |
- |
151.23 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
151.23 Mn |
| Dec 31, 2025 |
-6.67 Mn |
| Sep 30, 2025 |
10.50 Mn |
| Jun 30, 2025 |
33.91 Mn |
| Mar 31, 2025 |
-5.29 Mn |
| Dec 31, 2024 |
18.43 Mn |
| Sep 30, 2024 |
41.22 Mn |
| Jun 30, 2024 |
63.57 Mn |
| Mar 31, 2024 |
83.58 Mn |
| Dec 31, 2023 |
28.93 Mn |
| Sep 30, 2023 |
48.41 Mn |
| Jun 30, 2023 |
69.28 Mn |
| Mar 31, 2023 |
91.22 Mn |
| Dec 31, 2022 |
113.68 Mn |
| Sep 30, 2022 |
108.81 Mn |
| Jun 30, 2022 |
127.85 Mn |
| Mar 31, 2022 |
137.96 Mn |
| Dec 31, 2021 |
127.12 Mn |
| Sep 30, 2021 |
145.47 Mn |
| Jun 30, 2021 |
120.74 Mn |
